Clinical Trial Update: IL2 Imaging in Metastatic Melanoma [NA]

View source ↗

Summary

A clinical trial studying IL-2 imaging for metastatic melanoma conducted by University Medical Center Groningen has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• IL-2 imaging agent (interleukin-2 imaging agent)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Melanoma | NA | Status: TERMINATED